MedPath

Ranbaxy Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Established
1996-08-30
Employees
-
Market Cap
-
Website

Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
26
Registration Number
NCT00778050
Locations
🇺🇸

PRACS Institute Ltd., Fargo, North Dakota, United States

Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
36
Registration Number
NCT00778141
Locations
🇺🇸

Gateway medical research, St. Charles, Missouri, United States

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
30
Registration Number
NCT00778674
Locations
🇺🇸

aaiPharma, Inc., Chapel Hill, North Carolina, United States

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
60
Registration Number
NCT00778791
Locations
🇺🇸

Gateway medical research, St. Charles, Missouri, United States

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
35
Registration Number
NCT00778557
Locations
🇨🇦

Biovail Contract Research, Toronto, Ontario, Canada

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: 400 mg Gabapentin Capsules
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
24
Registration Number
NCT00778765
Locations
🇨🇦

MDS Pharma Services, Saint-Laurent,, Quebec, Canada

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
28
Registration Number
NCT00778401
Locations
🇺🇸

PRACS Institute Ltd., Fargo, North Dakota, United States

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
34
Registration Number
NCT00777972
Locations
🇺🇸

Gateway Medical Research Inc, St Charles, Missouri, United States

Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
44
Registration Number
NCT00778180
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00778466
Locations
🇺🇸

NovumPharmaceutical Research Services, Las Vegas, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath